Page 92 - Read Online

Page 12 of 15 Della Corte et al. Hepatoma Res 2022;8:5 https://dx.doi.org/10.20517/2394-5079.2021.103

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2022.

REFERENCES
1. Banales JM, Marin JJG, Lamarca A, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev
Gastroenterol Hepatol 2020;17:557-88. DOI PubMed PMC
2. Banales JM, Cardinale V, Carpino G, et al. Expert consensus document: Cholangiocarcinoma: current knowledge and future
perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev
Gastroenterol Hepatol 2016;13:261-80. DOI PubMed
3. Bertuccio P, Malvezzi M, Carioli G, et al. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma. J Hepatol
2019;71:104-14. DOI PubMed
4. Khan SA, Tavolari S, Brandi G. Cholangiocarcinoma: epidemiology and risk factors. Liver Int 2019;39 Suppl 1:19-31. DOI PubMed
5. Jang MH, Lee YJ, Kim H. Intrahepatic cholangiocarcinoma arising in Caroli’s disease. Clin Mol Hepatol 2014;20:402-5. DOI
PubMed PMC
6. Petrick JL, Yang B, Altekruse SF, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: as
population-based study in SEER-Medicare. PLoS One 2017;12:e0186643. DOI PubMed PMC
7. Fernández-Ruiz M, Guerra-Vales JM, Colina-Ruizdelgado F. Comorbidity negatively influences prognosis in patients with
extrahepatic cholangiocarcinoma. World J Gastroenterol 2009;15:5279-86. DOI PubMed PMC
8. Joo I, Lee JM, Lee SM, Lee JS, Park JY, Han JK. Diagnostic accuracy of liver imaging reporting and data system (LI-RADS) v2014
for intrahepatic mass-forming cholangiocarcinomas in patients with chronic liver disease on gadoxetic acid-enhanced MRI. J Magn
Reson Imaging 2016;44:1330-8. DOI PubMed
9. Joo I, Lee JM. Imaging bile duct tumors: pathologic concepts, classification, and early tumor detection. Abdom Imaging 2013;38:1334-
50. DOI PubMed
10. Seo N, Kim SY, Lee SS, et al. Sclerosing cholangitis: clinicopathologic features, imaging spectrum, and systemic approach to
differential diagnosis. Korean J Radiol 2016;17:25-38. DOI PubMed PMC
11. Kim JY, Kim MH, Lee TY, et al. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a
prospective study compared with conventional imaging. Am J Gastroenterol 2008;103:1145-51. DOI PubMed
12. Moon CM, Bang S, Chung JB, et al. Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and
staging of cholangiocarcinomas. J Gastroenterol Hepatol 2008;23:759-65. DOI PubMed
13. Waisberg DR, Pinheiro RS, Nacif LS, et al. Resection for intrahepatic cholangiocellular cancer: new advances. Transl Gastroenterol
Hepatol 2018;3:60. DOI PubMed PMC
14. Tamandl D, Herberger B, Gruenberger B, Puhalla H, Klinger M, Gruenberger T. Influence of hepatic resection margin on recurrence
and survival in intrahepatic cholangiocarcinoma. Ann Surg Oncol 2008;15:2787-94. DOI PubMed
15. Park JJ, Cheon JH, Kwon JE, et al. Clinical outcomes and factors related to resectability and curability of EMR for early colorectal
cancer. Gastrointest Endosc 2011;74:1337-46. DOI PubMed
16. Kolarich AR, Shah JL, George TJ Jr, et al. Non-surgical management of patients with intrahepatic cholangiocarcinoma in the United
States, 2004-2015: an NCDB analysis. J Gastrointest Oncol 2018;9:536-45. DOI PubMed PMC
17. Boehm LM, Jayakrishnan TT, Miura JT, et al. Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic
cholangiocarcinoma. J Surg Oncol 2015;111:213-20. DOI PubMed
18. Kuriyama N, Usui M, Gyoten K, et al. Neoadjuvant chemotherapy followed by curative-intent surgery for perihilar
cholangiocarcinoma based on its anatomical resectability classification and lymph node status. BMC Cancer 2020;20:405. DOI
PubMed PMC
19. Anderson B, Doyle MBM. Surgical considerations of hilar cholangiocarcinoma. Surg Oncol Clin N Am 2019;28:601-17. DOI
PubMed
20. Ayuso JR, Pagés M, Darnell A. Imaging bile duct tumors: staging. Abdom Imaging 2013;38:1071-81. DOI PubMed
21. Hennedige TP, Neo WT, Venkatesh SK. Imaging of malignancies of the biliary tract- an update. Cancer Imaging 2014;14:14. DOI
PubMed PMC
22. Razumilava N, Gores GJ. Classification, diagnosis, and management of cholangiocarcinoma. Clin Gastroenterol Hepatol 2013;11:13-
21.e1; quiz e3. DOI PubMed PMC
23. Ruys AT, van Beem BE, Engelbrecht MR, Bipat S, Stoker J, Van Gulik TM. Radiological staging in patients with hilar
cholangiocarcinoma: a systematic review and meta-analysis. Br J Radiol 2012;85:1255-62. DOI PubMed PMC
24. Clements O, Eliahoo J, Kim JU, Taylor-Robinson SD, Khan SA. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a
systematic review and meta-analysis. J Hepatol 2020;72:95-103. DOI PubMed